A pill that costs $450 at one pharmacy costs $250 at the one across the street. For most of American history, patients had no way to know. GoodRx was built to change that - and Bobn L is running it.
Running the Machine That Made Drug Prices Visible
When GoodRx describes itself, it leads with simplicity: compare prescription prices, get a coupon, save money. The simplicity is deliberate. But what runs underneath it - real-time price data from 75,000 pharmacies, aggregated every day, delivered in under a second - is not simple at all.
Bobn L is the Chief Executive Officer of GoodRx, headquartered in Santa Monica, California. The company sits at a peculiar intersection: it is a consumer app, a healthcare platform, a B2B pharmaceutical partnerships business, and a telemedicine provider simultaneously. Running it means holding all four in view at once and not letting any one of them drift from the founding premise that started the whole thing.
That premise: that patients deserve to know what their medications cost. Not approximately. Not after a phone call to the insurance company. Before they get to the counter.
GoodRx exists because patients deserve to know what their medications cost before they get to the counter. You can't fix what you can't see.
GoodRx - Core MissionBuilt From a $450 Question
September 2011. Santa Monica, California. Three founders sit down to solve a problem that millions of Americans experience and almost nobody has tried to fix systematically.
Doug Hirsch, a former Vice President of Product at Facebook, had the original experience: a prescription he needed cost wildly different amounts at different pharmacies. Not a few dollars different. Hundreds of dollars different. And there was no way - not a website, not an app, not a phone number - to find out which pharmacy had the better price before you went.
Hirsch brought in Trevor Bezdek and Scott Marlette, who had helped build Facebook's photo application as one of the company's first 20 employees. The three of them built the first version of GoodRx by doing something unglamorous and necessary: they scraped pharmacy websites and called stores by phone to ask what medications cost. Line by line, drug by drug, city by city.
That manual data-gathering turned into a data product. The data product turned into a platform. By 2015, a million Americans a month were using it. By 2019, the company posted $66 million in net income. The problem was big enough to support a real business.
The Revenue Picture
GoodRx's growth from startup to near-billion-dollar company tracks a platform that became genuinely necessary. The numbers tell the story directly.
Going Public During a Pandemic
September 23, 2020. Most of the market was still in wait-and-see mode. The pandemic had gutted travel, retail, and hospitality. Healthcare was overwhelmed.
GoodRx went public anyway. The company priced its IPO at $33 per share - above the expected range of $24 to $28 - and raised more than $1.1 billion. The market valued GoodRx at approximately $12.7 billion.
The timing was a bet that healthcare cost transparency was not a luxury of a recovering economy. It was a baseline need, made more urgent by a moment when tens of millions of Americans were uninsured, underinsured, or newly on high-deductible plans because they'd just changed jobs - or lost them.
The bet has held. GoodRx closed 2024 with $792.3 million in revenue and $16.4 million in net income, returning to profitability after a period of heavy post-IPO investment. It is now a mature, cash-generating platform, not just a growth story.
More than three times the number of Starbucks locations in the United States.
GoodRx went public on Nasdaq in September 2020 at $33 per share, valuing the company at $12.7B.
Return to profitability after post-IPO investment phase - a mature business, not a growth story alone.
What 75,000 Pharmacies Actually Means
The 75,000 number is easy to say and hard to picture. There are roughly 21,000 Starbucks locations in the United States. GoodRx covers more than three times as many pharmacy locations - every major chain and the majority of independent stores.
At each of those locations, the platform provides real-time price comparisons and coupons that are, for many common medications, cheaper than using insurance. For patients without coverage, GoodRx functions not as a convenience feature but as essential infrastructure for actually getting a prescription filled.
The Math That Matters
The average American fills approximately 12 prescriptions per year. Nearly one in four Americans reports not filling a prescription due to cost. When GoodRx closes that gap at scale - millions of users, 75,000 pharmacies - the public health effect is measurable.
The technology running behind that scale is correspondingly serious. GoodRx's infrastructure includes Amazon Kinesis and Apache Kafka for real-time data streaming, Kubernetes for container orchestration, GraphQL for API flexibility, and Databricks and Google Cloud BigQuery for analytics. The operational complexity of maintaining accurate, live drug pricing at this scale is not an accident - it is a competitive moat.
The Stack That Powers It
GoodRx's technology choices signal an organization that has thought carefully about scale, real-time data, and the future of AI in healthcare. A sample of what's running under the hood:
The presence of OpenAI and Vertex AI in the stack - alongside MLflow and Databricks - indicates active work on machine learning applications, likely across search relevance, recommendations, and telehealth triage.
The Telehealth Bet
In 2019, GoodRx acquired HeyDoctor and launched GoodRx Care - a telemedicine service that allows patients to consult with licensed providers online and receive prescriptions, without insurance. The timing, in retrospect, was sharp: one year before telehealth went from niche service to mainstream necessity.
The telemedicine expansion is part of a larger strategic ambition. GoodRx is not content to be a coupon platform. It is building a consumer layer on top of the entire American healthcare cost journey: medication pricing, pharmacy access, provider consultations, pharmaceutical manufacturer affordability programs.
Acquisitions have filled in the map: HealthiNation (2021, health content production) and VitaCare Prescription Services (2022, prescription access programs) expanded the platform's reach into patient education and adherence. The Pharma Solutions division - now led by Laura Jensen as Chief Commercial Officer - connects pharmaceutical manufacturers directly to patients through the GoodRx platform.
The Business of Transparency
GoodRx's revenue model is worth understanding clearly, because it shapes everything about how the company operates.
The primary revenue stream runs through pharmacy benefit manager (PBM) relationships: when a GoodRx coupon is used at a pharmacy, the company receives a portion of the transaction. This creates a direct alignment between GoodRx's financial success and its core function - the company makes money when people fill prescriptions at lower prices.
A second substantial revenue stream comes from the Pharma Solutions division, where pharmaceutical manufacturers pay GoodRx to connect their affordability and patient access programs to patients already using the platform. A third comes from subscription products, including GoodRx Gold - a flat-fee membership that provides consistent pricing on a broad formulary of generics.
None of these require patients to pay GoodRx to use the core service. The platform remains free for the consumer. This is not charity; it is a deliberate choice about who to charge and how. The person at the pharmacy counter with a $200 co-pay is not the customer. The person who benefits when that $200 goes down to $40 is.
The platform is free for the consumer because the person at the counter with a $200 co-pay is not the customer - the person who benefits when that $200 goes to $40 is.
GoodRx Revenue PhilosophyThe Executives Behind GoodRx
GoodRx's leadership has evolved significantly since 2011. The co-founders - Doug Hirsch, Trevor Bezdek, and Scott Marlette - built the company from a phone call to pharmacies into a publicly traded platform. In April 2023, Hirsch and Bezdek stepped back from day-to-day operations, and Scott Wagner - former CEO, COO, and CFO of GoDaddy, where he helped triple revenue to approximately $3 billion - served as Interim CEO through December 2024.
In January 2025, Wendy Barnes was appointed President and CEO. Barnes brings over 30 years of pharmacy and medical benefits experience, including CEO of RxBenefits and senior leadership at Express Scripts, Rite Aid, and Premier Inc. She came up through the U.S. Air Force Medical Service Corps, spending a decade in military healthcare before moving to the commercial sector. Her mandate is to deepen GoodRx's partnerships with retail pharmacies, insurers, and pharmaceutical manufacturers, and to bring more brand affordability programs onto the platform.
The company supporting Barnes includes Chief Financial Officer Chris McGinnis (30 years of healthcare financial leadership), Chief Technology Officer Nitin Shingate (since December 2022), and Chief People Officer Vina Leite. It is a leadership team assembled around operational depth rather than startup mythology.
GoodRx by Year
GoodRx founded in Santa Monica by Trevor Bezdek, Doug Hirsch, and Scott Marlette. First version built by scraping pharmacy websites and calling stores by phone.
Platform reaches 1 million monthly users - proof that pricing transparency was a genuine consumer need.
$9M net income - early evidence the business model works.
$66M net income. Acquires HeyDoctor; launches GoodRx Care telemedicine service. Pre-pandemic, the timing is prescient.
IPO on Nasdaq (GDRX) at $33/share during the pandemic. Raises $1.1B. Market cap peaks near $12.7B. One of the year's most successful healthcare technology offerings.
Acquires HealthiNation for health content production. Continues platform expansion into patient education and adherence.
Acquires VitaCare Prescription Services. Nitin Shingate joins as CTO. Post-IPO investment phase drives revenue growth with margin compression.
Co-founders step aside. Scott Wagner (ex-GoDaddy CEO) appointed Interim CEO. FTC settlement for $1.5M over data practices. Company recalibrates operations.
$792.3M revenue; $16.4M net income - return to profitability. Platform scale continues to grow. Class action pharmacy lawsuit settled without admission of wrongdoing.
Wendy Barnes becomes permanent CEO. Chris McGinnis joins as CFO. Laura Jensen takes Chief Commercial Officer role. Company enters next growth phase with 30-year healthcare veteran at the helm.
Things Worth Knowing About GoodRx
GoodRx covers more pharmacy locations - 75,000+ - than there are Starbucks in the United States (approximately 21,000).
For many common generic medications, the GoodRx coupon price is lower than the insurance co-pay. The coupon beats the benefit.
GoodRx raised $1.1 billion in its IPO - during the peak of the COVID-19 pandemic, when most IPOs were on hold.
Two of GoodRx's three founders came from Facebook, including one of the platform's first 20 employees.
Annual revenue of $797M makes GoodRx larger than many regional hospital systems - from a codebase, not a building.
GoodRx operates across 50 states with 740 employees - a lean team for a platform serving tens of millions of prescription events annually.
What GoodRx Has Built
- Largest prescription price comparison platform in the United States, covering 75,000+ pharmacies
- $1.1 billion raised in Nasdaq IPO (GDRX) in September 2020
- Returned to profitability in 2024 with $16.4M net income on $792M revenue
- Expanded into telemedicine via GoodRx Care, providing online consultations and prescriptions
- Built one of the most comprehensive real-time pharmaceutical pricing databases in the US
- Grew from 1 million monthly users (2015) to one of the most-used healthcare apps in America
- Launched GoodRx Gold subscription - flat-fee pricing on generic medications
- Connected pharmaceutical manufacturers to patients through the Pharma Solutions platform
GoodRx Right Now
-
2025-07
Laura Jensen joins as Chief Commercial Officer and President of Pharma Solutions, deepening GoodRx's pharmaceutical manufacturer partnership capability.
-
2025-02
Chris McGinnis named Chief Financial Officer, bringing 30+ years of healthcare financial leadership to support the company's return to profitability.
-
2025-01
Wendy Barnes appointed President and CEO, succeeding Scott Wagner as permanent CEO. Barnes brings 30 years of pharmacy and medical benefits leadership.
-
2024-12
Q3 2024 results confirm return to profitability; revenue trend continues toward $800M annual run rate.
-
2024-11
Class action lawsuit filed by independent pharmacies settled; no admission of wrongdoing. Platform continues normal operations.